Radiation-Induced Changes in Ventricular Myocardium After Stereotactic Body Radiotherapy for Recurrent Ventricular Tachycardia.


Journal

JACC. Clinical electrophysiology
ISSN: 2405-5018
Titre abrégé: JACC Clin Electrophysiol
Pays: United States
ID NLM: 101656995

Informations de publication

Date de publication:
12 2021
Historique:
received: 05 05 2021
revised: 26 07 2021
accepted: 26 07 2021
pubmed: 4 10 2021
medline: 3 2 2022
entrez: 3 10 2021
Statut: ppublish

Résumé

Stereotactic body radiotherapy (SBRT) has been suggested as a promising therapeutic alternative in cases of failed catheter ablation for recurrent ventricular tachycardias (VTs) in patients with structural heart disease. This case series is the first postmortem immunohistochemical analysis of morphologic changes in the myocardium early and late after SBRT. The present findings are in line with experimental observations on apoptosis followed by fibrosis. This may explain why the effect of SBRT on VT is not predominantly immediate. Together with observation of early recurrences after SBRT for VT, these data suggest that this strategy may have rather delayed antiarrhythmic effects.

Identifiants

pubmed: 34600851
pii: S2405-500X(21)00687-3
doi: 10.1016/j.jacep.2021.07.012
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1487-1492

Informations de copyright

Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures This work was supported by grant project AZV NU20-02-00244 from the Ministry of Health of the Czech Republic and by funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 945119. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Josef Kautzner (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: josef.kautzner@ikem.cz.

Kristina Jedlickova (K)

Department of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Marek Sramko (M)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Petr Peichl (P)

Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Jakub Cvek (J)

Department of Oncology, University Hospital Ostrava, Ostrava, Czech Republic.

Lukas Knybel Ing (LK)

Department of Oncology, University Hospital Ostrava, Ostrava, Czech Republic.

Radek Neuwirth (R)

Masaryk University, Brno, Czech Republic; Agel Hospital Trinec Podlesi a.s., Trinec, Czech Republic.

Otakar Jiravsky (O)

Masaryk University, Brno, Czech Republic; Agel Hospital Trinec Podlesi a.s., Trinec, Czech Republic.

Ludek Voska (L)

Department of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Tomas Kucera (T)

Institute of Histology and Embryology, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH